Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Connect Chemical is a global specialty chemical company headquartered in Ratingen, Germany, specializing in the development, production, and distribution of high-quality chemical intermediates and additives. The company serves as a strategic partner for the life sciences, personal care, and industrial sectors, offering a comprehensive portfolio that includes pharmaceutical intermediates, preservatives, and UV filters. In addition to its distribution business, Connect Chemical provides custom manufacturing (CMO/CDMO) services, leveraging its technical expertise and manufacturing facilities in China to support client-specific synthesis projects. In September 2022, the company was acquired by the KRAHN Chemie Group, a subsidiary of the Otto Krahn Group, to enhance its international distribution capabilities and product specialized knowledge. The firm is particularly recognized as a leading global supplier of Piroctone Olamine and other specialty actives for the cosmetic and pharmaceutical industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Connect Chemical.